“Those are the people who would be most likely to reach that eight-month period, because that’s how we prioritized initial immunizations back in January. So, I don’t think there’s huge differences here. I think the big news is that they actually did approve the initiation of boosters, and remember, they are taking a snapshot of right now.
“We’re going to see what happens in the coming weeks. It would surprise me if it does not become clear over the next few weeks that that administration of boosters may need to be enlarged. Based upon the data that was already seen both in the U.S. and in Israel, it’s clear the waning of the effectiveness of those vaccines is a reality, and we need to respond to it, but they looked at where we were on Friday and said here’s where the data is convincing to start now and we’ll see what CDC says later this week,” he said.
Wallace asked the director if he does “still think we are going to near booster program for everyone?
“I’m not sure about absolutely everyone. We’ll have to see what they say ultimately about the youngest individuals because of concerns about benefits and risks, but I will be surprised if boosters are not recommended for people under 65 going forward in the next few weeks, but we’ll wait and see. You know, Chris, what you’re seeing here is science playing out in a very transparent way. This is the way it ought to be. I’m a little troubled that people are complaining that the process isn’t working for them. The process is to look at the data, have the experts consider it and then make their best judgments — at that point, recognizing that the judgments may change. If people want an absolutely authoritative statement about here’s the right answer — well, that’s not what our country is all about. Move to China, you’ll get it there,” he said.
But Wallace pressed on, using Biden’s own words against him.
“Back during the campaign, he talked a lot about ‘follow the science,’” he said. “Isn’t announcing a specific date, and a specific plan, for the general population before any of the regulators — the FDA, the CDC — have approved it, isn’t that the exact opposite of ‘follow the science?’”